KPC Pharmaceuticals Inc (600422) - Total Assets
Based on the latest financial reports, KPC Pharmaceuticals Inc (600422) holds total assets worth CN¥12.01 Billion CNY (≈ $1.76 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can KPC Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
KPC Pharmaceuticals Inc - Total Assets Trend (1997–2024)
This chart illustrates how KPC Pharmaceuticals Inc's total assets have evolved over time, based on quarterly financial data. See KPC Pharmaceuticals Inc net assets for net asset value and shareholders' equity analysis.
KPC Pharmaceuticals Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
KPC Pharmaceuticals Inc's total assets of CN¥12.01 Billion consist of 67.8% current assets and 32.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 18.0% |
| Accounts Receivable | CN¥3.98 Billion | 31.6% |
| Inventory | CN¥1.54 Billion | 12.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥631.87 Million | 5.0% |
| Goodwill | CN¥1.50 Billion | 11.9% |
Asset Composition Trend (1997–2024)
This chart illustrates how KPC Pharmaceuticals Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 600422 market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: KPC Pharmaceuticals Inc's current assets represent 67.8% of total assets in 2024, an increase from 61.7% in 1997.
- Cash Position: Cash and equivalents constituted 18.0% of total assets in 2024, up from 8.8% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 2.0% in 1997.
- Asset Diversification: The largest asset category is accounts receivable at 31.6% of total assets.
KPC Pharmaceuticals Inc Competitors by Total Assets
Key competitors of KPC Pharmaceuticals Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
JW Pharmaceutical Corp
KO:001067
|
Korea | ₩611.56 Billion |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
Guilin Sanjin Pharmaceutical Co Ltd
SHE:002275
|
China | CN¥4.30 Billion |
|
Fuan Pharmaceutical Group Co
SHE:300194
|
China | CN¥5.97 Billion |
|
DRI Healthcare Trust
TO:DHT-U
|
Canada | $967.26 Million |
|
Hainan Shuangcheng Pharmaceut
SHE:002693
|
China | CN¥816.14 Million |
KPC Pharmaceuticals Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.93 | 1.91 | 1.78 |
| Quick Ratio | 1.58 | 1.51 | 1.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.84 Billion | CN¥3.60 Billion | CN¥2.44 Billion |
KPC Pharmaceuticals Inc - Advanced Valuation Insights
This section examines the relationship between KPC Pharmaceuticals Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.78 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | 31.8% |
| Total Assets | CN¥12.61 Billion |
| Market Capitalization | $969.23 Million USD |
Valuation Analysis
Below Book Valuation: The market values KPC Pharmaceuticals Inc's assets below their book value (0.08x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: KPC Pharmaceuticals Inc's assets grew by 31.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for KPC Pharmaceuticals Inc (1997–2024)
The table below shows the annual total assets of KPC Pharmaceuticals Inc from 1997 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥12.61 Billion ≈ $1.85 Billion |
+31.84% |
| 2023-12-31 | CN¥9.57 Billion ≈ $1.40 Billion |
+1.41% |
| 2022-12-31 | CN¥9.43 Billion ≈ $1.38 Billion |
+6.06% |
| 2021-12-31 | CN¥8.89 Billion ≈ $1.30 Billion |
+9.49% |
| 2020-12-31 | CN¥8.12 Billion ≈ $1.19 Billion |
+9.24% |
| 2019-12-31 | CN¥7.43 Billion ≈ $1.09 Billion |
+7.88% |
| 2018-12-31 | CN¥6.89 Billion ≈ $1.01 Billion |
+8.73% |
| 2017-12-31 | CN¥6.34 Billion ≈ $927.47 Million |
+17.32% |
| 2016-12-31 | CN¥5.40 Billion ≈ $790.52 Million |
+9.17% |
| 2015-12-31 | CN¥4.95 Billion ≈ $724.09 Million |
+63.63% |
| 2014-12-31 | CN¥3.02 Billion ≈ $442.52 Million |
+4.79% |
| 2013-12-31 | CN¥2.89 Billion ≈ $422.29 Million |
+34.11% |
| 2012-12-31 | CN¥2.15 Billion ≈ $314.87 Million |
+32.02% |
| 2011-12-31 | CN¥1.63 Billion ≈ $238.50 Million |
+15.11% |
| 2010-12-31 | CN¥1.42 Billion ≈ $207.20 Million |
+13.81% |
| 2009-12-31 | CN¥1.24 Billion ≈ $182.06 Million |
+7.53% |
| 2008-12-31 | CN¥1.16 Billion ≈ $169.30 Million |
-2.79% |
| 2007-12-31 | CN¥1.19 Billion ≈ $174.16 Million |
+5.48% |
| 2006-12-31 | CN¥1.13 Billion ≈ $165.10 Million |
-8.89% |
| 2005-12-31 | CN¥1.24 Billion ≈ $181.21 Million |
+5.66% |
| 2004-12-31 | CN¥1.17 Billion ≈ $171.49 Million |
+23.79% |
| 2003-12-31 | CN¥946.71 Million ≈ $138.53 Million |
+24.03% |
| 2002-12-31 | CN¥763.28 Million ≈ $111.69 Million |
-0.09% |
| 2001-12-31 | CN¥763.98 Million ≈ $111.79 Million |
-4.36% |
| 2000-12-31 | CN¥798.80 Million ≈ $116.89 Million |
+83.58% |
| 1999-12-31 | CN¥435.12 Million ≈ $63.67 Million |
+7.32% |
| 1998-12-31 | CN¥405.44 Million ≈ $59.33 Million |
+33.26% |
| 1997-12-31 | CN¥304.23 Million ≈ $44.52 Million |
-- |
About KPC Pharmaceuticals Inc
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotics,… Read more